Syros Pharmaceuticals Inc (NASDAQ:SYRS)

4.49
Delayed Data
As of Jan 27
 0.00 / 0.00%
Today’s Change
3.02
Today|||52-Week Range
21.90
+25.07%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Syros Pharmaceuticals Inc have a median target of 16.00, with a high estimate of 60.00 and a low estimate of 15.00. The median estimate represents a +256.35% increase from the last price of 4.49.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Syros Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.23
Sales
$3.9M
Reporting Date
Mar 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 61.84%
 
 
 
 
 
 
Growthannually 32.13%
 
 
 
 
 
 

Sales

Growthquarterly -1.05%
 
 
 
 
 
 
Growthannually -17.12%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.